Market Cap 3.93B
Revenue (ttm) 1.36B
Net Income (ttm) 167.68M
EPS (ttm) N/A
PE Ratio 17.46
Forward PE 17.01
Profit Margin 12.32%
Debt to Equity Ratio 1.08
Volume 746,200
Avg Vol 883,250
Day's Range N/A - N/A
Shares Out 46.81M
Stochastic %K 85%
Beta 0.30
Analysts Strong Sell
Price Target $81.70

Company Profile

Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLy...

Industry: Medical Devices
Sector: Healthcare
Phone: 781 848 7100
Address:
125 Summer Street, Boston, United States
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:32 AM
$HAE Analysis: The last close at $83.81 indicates a strong upward momentum, especially with an RSI of 91.25, suggesting overbought conditions. The 30-day moving average (MA30) at 67.7 and 50-day moving average (MA50) at 60.45 further confirm the bullish trend, as the price is significantly above these averages. The recent 60-day high of $84.19 indicates resistance, while the low of $47.32 shows the potential for significant gains. Actionable Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.0% risk) - Take Profit Targets: 1. $86.00 (2.7% gain) 2. $89.00 (6.8% gain) 3. $98.00 (17% gain) With the current market context and directional bias favoring upward movement, this trade plan allows for a structured approach to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:07 PM
$HAE Analysis: The last close at $83.81 indicates a strong upward momentum, especially with an RSI of 91.25, suggesting overbought conditions. The 30-day moving average (MA30) at 67.7 and 50-day moving average (MA50) at 60.45 further confirm the bullish trend, as the price is significantly above these averages. The recent 60-day high of $84.19 indicates resistance, while the low of $47.32 shows the potential for significant gains. Actionable Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.0% risk) - Take Profit Targets: 1. $86.00 (2.7% gain) 2. $89.00 (6.8% gain) 3. $98.00 (17% gain) With the current market context and directional bias favoring upward movement, this trade plan allows for a structured approach to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
stockanalysis_
stockanalysis_ Dec. 5 at 1:07 AM
Overbought Stocks: $MAGH $SND $HAE $EXAS $CDTX View the entire list here: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
0 · Reply
Estimize
Estimize Dec. 1 at 2:03 PM
Wall St is expecting 1.25 EPS for $HAE Q3 [Reporting 02/10 BMO] http://www.estimize.com/intro/hae?chart=historical&metric_name=eps&utm_cont
0 · Reply
Cutlass
Cutlass Nov. 28 at 3:12 PM
$HAE Out for now - solid run from 48 💥
1 · Reply
Cutlass
Cutlass Nov. 25 at 3:37 PM
$HAE Trim a bit 81.25 and every dollar up 👀
0 · Reply
Cutlass
Cutlass Nov. 24 at 5:43 PM
$HAE Trim a tad at 80 🍎
0 · Reply
stockanalysis_
stockanalysis_ Nov. 22 at 4:00 PM
Overbought Stocks: $EXAS $HAE $FRGE $CDTX $BACC.X Bookmark this page: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
0 · Reply
FlaMeZ907
FlaMeZ907 Nov. 21 at 6:26 PM
$HAE What's up with all these crappy bio pharma companies going up in a straight line? 👩🏻‍⚕️
3 · Reply
Cutlass
Cutlass Nov. 21 at 4:08 PM
$HAE Trim 77 🍎
0 · Reply
Latest News on HAE
Top 2 Health Care Stocks You May Want To Dump This Month

Dec 2, 2025, 9:01 AM EST - 4 days ago

Top 2 Health Care Stocks You May Want To Dump This Month

EXAS


Why Haemonetics Stock Was on Fire Thursday

Nov 7, 2025, 12:47 PM EST - 4 weeks ago

Why Haemonetics Stock Was on Fire Thursday


Haemonetics Is Still Undervalued, Even After The Rally

Nov 7, 2025, 10:41 AM EST - 4 weeks ago

Haemonetics Is Still Undervalued, Even After The Rally


Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript

Aug 9, 2025, 10:53 PM EDT - 4 months ago

Haemonetics Corporation (HAE) Q1 2026 Earnings Call Transcript


Haemonetics (HAE) Q1 Revenue Falls 4%

Aug 7, 2025, 6:33 AM EDT - 4 months ago

Haemonetics (HAE) Q1 Revenue Falls 4%


Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript

May 10, 2025, 1:05 PM EDT - 7 months ago

Haemonetics Corporation (HAE) Q4 2025 Earnings Call Transcript


Haemonetics Announces Executive Leadership Updates

Mar 3, 2025, 4:10 PM EST - 9 months ago

Haemonetics Announces Executive Leadership Updates


Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript

Feb 6, 2025, 12:19 PM EST - 10 months ago

Haemonetics Corporation (HAE) Q3 2025 Earnings Call Transcript


Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A

Jan 14, 2025, 6:13 AM EST - 11 months ago

Haemonetics Completes Sale of Whole Blood Assets to GVS, S.p.A


Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript

May 10, 2024, 12:25 AM EDT - 1 year ago

Haemonetics Corporation (HAE) Q4 2024 Earnings Call Transcript


PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:32 AM
$HAE Analysis: The last close at $83.81 indicates a strong upward momentum, especially with an RSI of 91.25, suggesting overbought conditions. The 30-day moving average (MA30) at 67.7 and 50-day moving average (MA50) at 60.45 further confirm the bullish trend, as the price is significantly above these averages. The recent 60-day high of $84.19 indicates resistance, while the low of $47.32 shows the potential for significant gains. Actionable Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.0% risk) - Take Profit Targets: 1. $86.00 (2.7% gain) 2. $89.00 (6.8% gain) 3. $98.00 (17% gain) With the current market context and directional bias favoring upward movement, this trade plan allows for a structured approach to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:07 PM
$HAE Analysis: The last close at $83.81 indicates a strong upward momentum, especially with an RSI of 91.25, suggesting overbought conditions. The 30-day moving average (MA30) at 67.7 and 50-day moving average (MA50) at 60.45 further confirm the bullish trend, as the price is significantly above these averages. The recent 60-day high of $84.19 indicates resistance, while the low of $47.32 shows the potential for significant gains. Actionable Trade Plan: - Suggested Entry: $83.50 - Stop Loss: $80.00 (3.0% risk) - Take Profit Targets: 1. $86.00 (2.7% gain) 2. $89.00 (6.8% gain) 3. $98.00 (17% gain) With the current market context and directional bias favoring upward movement, this trade plan allows for a structured approach to capitalize on the bullish trend while managing risk effectively. https://privateprofiteers.com
0 · Reply
stockanalysis_
stockanalysis_ Dec. 5 at 1:07 AM
Overbought Stocks: $MAGH $SND $HAE $EXAS $CDTX View the entire list here: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
0 · Reply
Estimize
Estimize Dec. 1 at 2:03 PM
Wall St is expecting 1.25 EPS for $HAE Q3 [Reporting 02/10 BMO] http://www.estimize.com/intro/hae?chart=historical&metric_name=eps&utm_cont
0 · Reply
Cutlass
Cutlass Nov. 28 at 3:12 PM
$HAE Out for now - solid run from 48 💥
1 · Reply
Cutlass
Cutlass Nov. 25 at 3:37 PM
$HAE Trim a bit 81.25 and every dollar up 👀
0 · Reply
Cutlass
Cutlass Nov. 24 at 5:43 PM
$HAE Trim a tad at 80 🍎
0 · Reply
stockanalysis_
stockanalysis_ Nov. 22 at 4:00 PM
Overbought Stocks: $EXAS $HAE $FRGE $CDTX $BACC.X Bookmark this page: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
0 · Reply
FlaMeZ907
FlaMeZ907 Nov. 21 at 6:26 PM
$HAE What's up with all these crappy bio pharma companies going up in a straight line? 👩🏻‍⚕️
3 · Reply
Cutlass
Cutlass Nov. 21 at 4:08 PM
$HAE Trim 77 🍎
0 · Reply
JarvisFlow
JarvisFlow Nov. 21 at 3:01 PM
BTIG updates rating for Haemonetics ( $HAE ) to Buy, target set at 88.
0 · Reply
johnmilnes
johnmilnes Nov. 20 at 7:40 PM
$HAE What a thing of beauty....
0 · Reply
Cutlass
Cutlass Nov. 20 at 4:00 PM
$HAE 75 gap closed, trim 76 and will trim every dollar up for now - 😎
0 · Reply
BEATOFtheMARKET
BEATOFtheMARKET Nov. 17 at 12:43 AM
0 · Reply
Cutlass
Cutlass Nov. 12 at 3:49 PM
$HAE Will trim more at 74, then 75...will then hold a runner. Gap 75.13 from last ER -
0 · Reply
Cutlass
Cutlass Nov. 12 at 3:39 PM
$HAE Trim a tad 73 ✅
0 · Reply
Cutlass
Cutlass Nov. 11 at 5:42 PM
$HAE Trim a bit 72 -
0 · Reply
Sellasgps26BAT10
Sellasgps26BAT10 Nov. 10 at 8:09 PM
$CIFR $CSGP $FDP $HAE $SLS Every company on your list presenting is $20.00- $70.00. SLS only one at $1.52 for now. ✌️🙏
1 · Reply
Cutlass
Cutlass Nov. 10 at 7:36 PM
$HAE Trim a bit 71 🎉
0 · Reply
G101SPM
G101SPM Nov. 10 at 7:34 PM
#SHOWTIME J.P. Morgan U.S. Opportunities Forum (November 11-12) Scheduled to appear: $CIFR, $CSGP, $FDP, $HAE, $SLS
0 · Reply
N0_Brainers
N0_Brainers Nov. 7 at 1:50 PM
0 · Reply
JarvisFlow
JarvisFlow Nov. 7 at 1:14 PM
Barrington Research has adjusted their stance on Haemonetics ( $HAE ), setting the rating to Outperform with a target price of 86 → 90.
0 · Reply